198 related articles for article (PubMed ID: 20133500)
1. IDH1 gene mutations: a new paradigm in glioma prognosis and therapy?
Labussiere M; Sanson M; Idbaih A; Delattre JY
Oncologist; 2010; 15(2):196-9. PubMed ID: 20133500
[TBL] [Abstract][Full Text] [Related]
2. Role of isocitrate dehydrogenase in glioma.
Alexander BM; Mehta MP
Expert Rev Neurother; 2011 Oct; 11(10):1399-409. PubMed ID: 21955197
[TBL] [Abstract][Full Text] [Related]
3. Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastoma.
Agnihotri S; Aldape KD; Zadeh G
Neurosurg Focus; 2014 Dec; 37(6):E13. PubMed ID: 25434382
[TBL] [Abstract][Full Text] [Related]
4. From standard treatment to personalized medicine: role of IDH1 mutations in low-grade glioma evolution and treatment.
Ferroli P; Acerbi F; Finocchiaro G
World Neurosurg; 2010 Apr; 73(4):234-6. PubMed ID: 20849763
[No Abstract] [Full Text] [Related]
5. Isocitrate dehydrogenase mutations in gliomas.
Waitkus MS; Diplas BH; Yan H
Neuro Oncol; 2016 Jan; 18(1):16-26. PubMed ID: 26188014
[TBL] [Abstract][Full Text] [Related]
6. IDH mutations in glioma and acute myeloid leukemia.
Dang L; Jin S; Su SM
Trends Mol Med; 2010 Sep; 16(9):387-97. PubMed ID: 20692206
[TBL] [Abstract][Full Text] [Related]
7. Isocitrate dehydrogenase 1 mutation subtypes at site 132 and their translational potential in glioma.
Lu VM; McDonald KL
CNS Oncol; 2018 Jan; 7(1):41-50. PubMed ID: 29303363
[TBL] [Abstract][Full Text] [Related]
8. Isocitrate dehydrogenase 1: what it means to the neurosurgeon: a review.
Hodges TR; Choi BD; Bigner DD; Yan H; Sampson JH
J Neurosurg; 2013 Jun; 118(6):1176-80. PubMed ID: 23581583
[TBL] [Abstract][Full Text] [Related]
9. What do we know about IDH1/2 mutations so far, and how do we use it?
Horbinski C
Acta Neuropathol; 2013 May; 125(5):621-36. PubMed ID: 23512379
[TBL] [Abstract][Full Text] [Related]
10. Glioma-derived mutations in IDH: from mechanism to potential therapy.
Fu Y; Huang R; Du J; Yang R; An N; Liang A
Biochem Biophys Res Commun; 2010 Jun; 397(2):127-30. PubMed ID: 20510884
[TBL] [Abstract][Full Text] [Related]
11. Evaluating Mechanisms of IDH1 Regulation through Site-Specific Acetylation Mimics.
Weeks J; Strom AI; Widjaja V; Alexander S; Pucher DK; Sohl CD
Biomolecules; 2021 May; 11(5):. PubMed ID: 34065652
[TBL] [Abstract][Full Text] [Related]
12. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.
Sanson M; Marie Y; Paris S; Idbaih A; Laffaire J; Ducray F; El Hallani S; Boisselier B; Mokhtari K; Hoang-Xuan K; Delattre JY
J Clin Oncol; 2009 Sep; 27(25):4150-4. PubMed ID: 19636000
[TBL] [Abstract][Full Text] [Related]
13. Isocitrate dehydrogenase mutation as a therapeutic target in gliomas.
Han CH; Batchelor TT
Chin Clin Oncol; 2017 Jun; 6(3):33. PubMed ID: 28705010
[TBL] [Abstract][Full Text] [Related]
14. The genomics of brain cancer.
DeWeerdt S
Nature; 2018 Sep; 561(7724):S54-S55. PubMed ID: 30258161
[No Abstract] [Full Text] [Related]
15. [Advance of molecular subtyping and precise treatment for gliomas].
Hua W; Mao Y
Zhonghua Wai Ke Za Zhi; 2017 Jan; 55(1):63-66. PubMed ID: 28056258
[TBL] [Abstract][Full Text] [Related]
16. Diffuse glioma - Rare homozygous IDH point mutation, is it an oncogenetic mechanism?
Singh A; Gurav M; Dhanavade S; Shetty O; Epari S
Neuropathology; 2017 Dec; 37(6):582-585. PubMed ID: 28782849
[TBL] [Abstract][Full Text] [Related]
17. IDH1 mutation diminishes aggressive phenotype in glioma stem cells.
Yao Q; Cai G; Yu Q; Shen J; Gu Z; Chen J; Shi W; Shi J
Int J Oncol; 2018 Jan; 52(1):270-278. PubMed ID: 29115585
[TBL] [Abstract][Full Text] [Related]
18. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
19. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
Hartmann C; Meyer J; Balss J; Capper D; Mueller W; Christians A; Felsberg J; Wolter M; Mawrin C; Wick W; Weller M; Herold-Mende C; Unterberg A; Jeuken JW; Wesseling P; Reifenberger G; von Deimling A
Acta Neuropathol; 2009 Oct; 118(4):469-74. PubMed ID: 19554337
[TBL] [Abstract][Full Text] [Related]
20. New developments in the pathogenesis and therapeutic targeting of the IDH1 mutation in glioma.
Dimitrov L; Hong CS; Yang C; Zhuang Z; Heiss JD
Int J Med Sci; 2015; 12(3):201-13. PubMed ID: 25678837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
